SEC 13F Intelligence

Zebra Capital Management LLC / PTCT

Zebra Capital Management LLC’s Ptc Therapeutics Inc Position

Does Zebra Capital Management LLC own Ptc Therapeutics Inc (PTCT)? Yes — 6.6K shares worth $320,000 (+1.60% of its 13F portfolio) as of Q1 2023, up from 5.3K shares the prior filed quarter.

Position Value
$320,000
Q1 2023
Shares
6.6K
% of Portfolio
+1.60%
Quarters Held
4
currently held

Position History PTCT

Reported value by quarter
Q3 ’21: $400,000Q3 ’21Q4 ’21: $313,000Q4 ’21Q3 ’22: $268,000Q3 ’22Q1 ’23: $320,000Q1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20236.6K$320,000+1.60%
Q3 20225.3K$268,000+1.02%
Q4 20217.9K$313,000+0.50%
Q3 202110.8K$400,000+0.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Zebra Capital Management LLC’s full portfolio or all institutional holders of PTCT.